News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Myeloma Paper of the Day, June 28th, suggested by Robert Orlowski
Jun 28, 2024, 12:53

Myeloma Paper of the Day, June 28th, suggested by Robert Orlowski

Robert Orlowski shared a post on X:

“Myeloma Paper of the Day: A deep learning model trained on whole body low dose CT scans may be able to predict the presence of cytogenetic abnormalities used for high risk stratification in myeloma: ”

Source: Robert Orlowski/X

Whole-body low-dose computed tomography in patients with newly diagnosed multiple myeloma predicts cytogenetic risk: a deep learning radiogenomics study

Authors: Shahriar Faghani, Mana Moassefi, Udit Yadav, Francis K. Buadi, Shaji K. Kumar, Bradley J. Erickson, Wilson I. Gonsalves and Francis I. Baffour.

Myeloma Paper of the Day, June 28th, suggested by Robert Orlowski

Other posts featuring Robert Orlowski on OncoDaily.

Robert Orlowski holds multiple positions at The University of Texas MD Anderson Cancer Center, including Chairman, Ad Interim Director of Myeloma, and Professor of Medicine in the Departments of Lymphoma/Myeloma and Experimental Therapeutics within the Division of Cancer Medicine.

Additionally, he chairs the SWOG Barlogie/Salmon Myeloma Committee, which is part of the National Clinical Trials Network, dedicated to advancing new therapies and understanding the biology of myeloma.

Bradley J. Erickson cancer cytogenetic abnormalities Francis I. Baffour Francis K. Buadi high risk stratification low dose CT scans Mana Moassefi MD Anderson Cancer Center Myeloma Myeloma Paper of the Day newly diagnosed multiple myeloma OncoDaily Oncology radiogenomics study Robert Orlowski Shahriar Faghani Shaji K. Kumar Udit Yadav Wilson I. Gonsalves
Special Coverage
Insight
Dec 19, 2024, 08:27
What role does mentorship play in building resilience? - ESMO
Blog
Dec 19, 2024, 08:16
The U.S. House of Representatives released text of the FY25 Continuing Resolution - ACS CAN
Insight
Dec 19, 2024, 08:12
Talha Badar: ASH24 abstract in acute leukemia and MDS
Blog
Dec 19, 2024, 08:08
T790M resistance mutations in EGFR+ lung cancer - EGFR Positive Lung Cancer UK
Positive
Dec 19, 2024, 08:03
Eric K. Singhi: Honored to be recognized as this year’s Emerging Leader by MUSC Alamni
Blog
Dec 19, 2024, 07:57
Marilyn Bui: Moffitt Cancer Center achieved the highest patient satisfaction score this year
Blog
Dec 19, 2024, 07:51
Laura Bukavina: The use of TMT for localized bladder cancer in octogenarians
Opinion
Dec 19, 2024, 07:45
Gustavo Viani: Stereotactic Body Radiation Therapy - Does scheduling matter?
Blog
Dec 19, 2024, 07:41
IMPACT Malignant Hematology Webinar on the evolving treatment landscape of lower-risk MDS - Vanderbilt-Ingram Cancer Center
Societies
Dec 19, 2024, 07:38
ASCOGI25 abstract titles are now available
Insight
Dec 19, 2024, 07:27
Geoffrey Shapiro Honored with MSCO Distinguished Researcher Award
Drugs
Dec 19, 2024, 07:24
U.S. FDA Grants Breakthrough Therapy Designation to Trodelvy®